Friday, August 29, 2014

Flexible Bioproduction Technologies & Facilities: Updates from the U.S. Part 2

In today's featured presentation from Biopharmaceutical Development and Production Week, Thomas Warf, Director, Manufacturing, Facilities and Engineering, BARDA, U.S. Department of Health & Human Services talks about how NOVARTIS has been with the US government since 2006, and how they are responsible for the occupancy of the new pilot facility for the first half of the year, BARDA is responsible for the 2nd half. Warf also mentions that the Chinese found a new influenza with a fatality rate of 62%-75% and how the fill and finish field is at 90% capacity. To learn more, watch the second part of Thomas Warf's presentation:

Did you miss Part 1 of Thomas Warf's presentation? Watch it here.

Are you interested in finding out more about Biopharmaceutical Development and Production Week's 2015 keynotes?  Sign up to receive email updates about the program which will take place March 30-April 2 in Huntington Beach, California.

Share this article with your social network, just click below to share now!

No comments :

Post a Comment